| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 14.236 | 11.504 | 17.767 | 32.333 | 19.867 | 16.023 |
| Total Income - EUR | - | - | - | - | 14.267 | 11.514 | 17.768 | 32.356 | 19.873 | 16.032 |
| Total Expenses - EUR | - | - | - | - | 7.039 | 13.791 | 13.442 | 26.962 | 18.933 | 14.556 |
| Gross Profit/Loss - EUR | - | - | - | - | 7.228 | -2.278 | 4.326 | 5.394 | 940 | 1.476 |
| Net Profit/Loss - EUR | - | - | - | - | 6.801 | -2.621 | 3.793 | 4.441 | 386 | 879 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biokits Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 25 | 25 | 2.080 | 5.813 | 7.470 |
| Current Assets | - | - | - | - | 8.324 | 5.105 | 10.408 | 10.650 | 13.747 | 9.548 |
| Inventories | - | - | - | - | 231 | 86 | 136 | 0 | 249 | 247 |
| Receivables | - | - | - | - | 0 | 0 | 2.630 | 3 | 3.773 | 564 |
| Cash | - | - | - | - | 8.093 | 5.019 | 7.642 | 10.647 | 9.725 | 8.736 |
| Shareholders Funds | - | - | - | - | 6.843 | 4.093 | 7.795 | 12.261 | 12.610 | 13.363 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.506 | 1.037 | 2.637 | 469 | 6.950 | 3.655 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Biokits Lab S.r.l.